Hepatitis C cascade of care in the direct-acting antivirals era: a meta-analysis
Introduction The hepatitis C virus (HCV) epidemic remains a public health problem
worldwide. A systematic review and meta-analysis were conducted to provide evidence of …
worldwide. A systematic review and meta-analysis were conducted to provide evidence of …
[PDF][PDF] Hepatitis C Virus Prevalence, Screening, and Treatment Among People Who Are Incarcerated in Canada: Leaving No One Behind in the Direct‐Acting Antiviral …
Hepatitis C Virus Prevalence, Screening, and Treatment Among People Who Are Incarcerated
in Canada: Leaving No One Behind in the Page 1 75 | CliniCal liver Disease, vOl 17, nO 2 …
in Canada: Leaving No One Behind in the Page 1 75 | CliniCal liver Disease, vOl 17, nO 2 …
[HTML][HTML] The cascade of care for hepatitis C treatment in Rwanda: a retrospective cohort study of the 2017–2019 mass screening and treatment campaign
Access to hepatitis C (HCV) testing and treatment is still limited globally. To address this, the
Government of Rwanda launched a voluntary mass screening and treatment campaign in …
Government of Rwanda launched a voluntary mass screening and treatment campaign in …
[HTML][HTML] HCV treatment initiation in the era of universal direct acting antiviral coverage–Improvements in access and persistent barriers
N Jiang, J Bruneau, I Makarenko, N Minoyan… - International Journal of …, 2023 - Elsevier
Background Barriers to HCV treatment initiation persisted after the introduction of direct-
acting antivirals (DAAs) in Canada among people who inject drugs (PWID); whether DAA …
acting antivirals (DAAs) in Canada among people who inject drugs (PWID); whether DAA …
A randomized pilot study assessing the acceptability of rapid point-of-care hepatitis C virus (HCV) testing among male inmates in Montreal, Canada
N Kronfli, C Dussault, S Chalifoux, H Kavoukian… - International Journal of …, 2020 - Elsevier
Abstract Background The OraquickⓇ fingerprick point-of-care hepatitis C virus antibody
(HCV-Ab) test is favoured to venipuncture among people who inject drugs; however, its …
(HCV-Ab) test is favoured to venipuncture among people who inject drugs; however, its …
[HTML][HTML] Identifying barriers and enablers to opt-out hepatitis C virus screening in provincial prisons in Quebec, Canada: A multilevel, multi-theory informed qualitative …
Background Diffuse implementation of hepatitis C virus (HCV) treatment is dependent on
universal screening for HCV, but screening strategies are heterogenous across prisons in …
universal screening for HCV, but screening strategies are heterogenous across prisons in …
[HTML][HTML] Antimicrobial Use and Stewardship: National Hepatitis C estimates: Incidence, prevalence, undiagnosed proportion and treatment, Canada, 2019
N Popovic, A Williams, S Périnet… - Canada …, 2022 - ncbi.nlm.nih.gov
Background Estimates of the number of hepatitis C virus (HCV) infections are important for
monitoring efforts aimed at preventing disease transmission, especially following the …
monitoring efforts aimed at preventing disease transmission, especially following the …
Public reimbursement policies in Canada for direct-acting antiviral treatment of hepatitis C virus infection: A descriptive study
G Snell, AD Marshall, J van Gennip… - Canadian Liver …, 2023 - canlivj.utpjournals.press
Background: Direct-acting antiviral (DAA) therapies have simplified HCV treatment, and
publicly funded Canadian drug plans have eliminated disease-stage restrictions for …
publicly funded Canadian drug plans have eliminated disease-stage restrictions for …
Implementing opt-out hepatitis C virus (HCV) screening in Canadian provincial prisons: A model-based cost-effectiveness analysis
L Duchesne, C Dussault, A Godin… - International Journal of …, 2021 - Elsevier
Background Implementing opt-out hepatitis C virus (HCV) screening across Canadian
provincial prisons is crucial to achieving micro-elimination. Given short incarceration …
provincial prisons is crucial to achieving micro-elimination. Given short incarceration …
[HTML][HTML] The hepatitis C virus care cascade in the New York City jail system during the direct acting antiviral treatment era, 2014–2017
J Chan, F Kaba, J Schwartz, A Bocour… - …, 2020 - thelancet.com
Background High patient turnover presents challenges and opportunity to provide hepatitis
C virus (HCV) care in US jails (remand facilities). This study describes the HCV care …
C virus (HCV) care in US jails (remand facilities). This study describes the HCV care …